AbbVie
ABBV
#25
Rank
A$606.16 B
Marketcap
A$342.97
Share price
0.48%
Change (1 day)
22.16%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$71.31 M-63.85%
2024A$0.19 B-13.93%
2023A$0.22 B-63.52%
2022A$0.62 B629.28%
2021A$86.13 M-77.97%
2020A$0.39 B85.64%
2019A$0.21 B-52.97%
2018A$0.44 B269.88%
2017A$0.12 B-48.45%
2016A$0.23 B-37.53%
2015A$0.37 B-44.13%
2014A$0.67 B2387.79%
2013A$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
A$29.26 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.67 MA$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$0.29 BA$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$21.81 MA$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$36.76 MA$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.15 MA$78.49 M๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$61.56 MA$0.39 B๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
A$28.29 MA$0.10 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$2.78 MA$30.57 M๐Ÿ‡บ๐Ÿ‡ธ USA